nodes	percent_of_prediction	percent_of_DWPC	metapath
Abacavir—ADH6—Fatty Acid Omega Oxidation—CYP3A4—bone cancer	0.0761	0.282	CbGpPWpGaD
Abacavir—ADK—Nucleotide metabolism—NT5C3A—bone cancer	0.0332	0.123	CbGpPWpGaD
Abacavir—ADH6—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.0214	0.0794	CbGpPWpGaD
Abacavir—UGT1A1—Codeine and Morphine Metabolism—CYP3A4—bone cancer	0.0209	0.0776	CbGpPWpGaD
Abacavir—UGT1A1—Irinotecan Pathway—CYP3A4—bone cancer	0.0134	0.0496	CbGpPWpGaD
Abacavir—ADH6—Biological oxidations—CYP3A4—bone cancer	0.0114	0.0422	CbGpPWpGaD
Abacavir—UGT1A1—Estrogen metabolism—CYP3A4—bone cancer	0.0109	0.0405	CbGpPWpGaD
Abacavir—ADH6—Biological oxidations—GSTP1—bone cancer	0.00974	0.0361	CbGpPWpGaD
Abacavir—UGT1A1—Metapathway biotransformation—CYP4V2—bone cancer	0.00897	0.0332	CbGpPWpGaD
Abacavir—UGT1A1—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.00691	0.0256	CbGpPWpGaD
Abacavir—ADH6—Metabolism—NDUFA12—bone cancer	0.00683	0.0253	CbGpPWpGaD
Abacavir—ADH6—Metabolism—NT5C3A—bone cancer	0.00566	0.0209	CbGpPWpGaD
Abacavir—ADK—Metabolism—NDUFA12—bone cancer	0.00364	0.0135	CbGpPWpGaD
Abacavir—Mouth ulceration—Epirubicin—bone cancer	0.00338	0.00463	CcSEcCtD
Abacavir—Influenza like illness—Doxorubicin—bone cancer	0.00336	0.00461	CcSEcCtD
Abacavir—Immune system disorder—Cisplatin—bone cancer	0.0033	0.00453	CcSEcCtD
Abacavir—Aplastic anaemia—Doxorubicin—bone cancer	0.00325	0.00445	CcSEcCtD
Abacavir—Neuropathy—Doxorubicin—bone cancer	0.00325	0.00445	CcSEcCtD
Abacavir—Alopecia—Cisplatin—bone cancer	0.00323	0.00443	CcSEcCtD
Abacavir—Hepatic failure—Methotrexate—bone cancer	0.00323	0.00442	CcSEcCtD
Abacavir—Malnutrition—Cisplatin—bone cancer	0.00318	0.00436	CcSEcCtD
Abacavir—Lymphadenopathy—Epirubicin—bone cancer	0.00318	0.00436	CcSEcCtD
Abacavir—Mouth ulceration—Doxorubicin—bone cancer	0.00313	0.00429	CcSEcCtD
Abacavir—Hepatic failure—Epirubicin—bone cancer	0.00302	0.00414	CcSEcCtD
Abacavir—ADK—Metabolism—NT5C3A—bone cancer	0.00302	0.0112	CbGpPWpGaD
Abacavir—Lethargy—Methotrexate—bone cancer	0.00296	0.00406	CcSEcCtD
Abacavir—Ill-defined disorder—Cisplatin—bone cancer	0.00296	0.00405	CcSEcCtD
Abacavir—Lymphadenopathy—Doxorubicin—bone cancer	0.00295	0.00403	CcSEcCtD
Abacavir—Anaemia—Cisplatin—bone cancer	0.00294	0.00403	CcSEcCtD
Abacavir—Malaise—Cisplatin—bone cancer	0.00287	0.00393	CcSEcCtD
Abacavir—Leukopenia—Cisplatin—bone cancer	0.00285	0.00391	CcSEcCtD
Abacavir—Hepatic failure—Doxorubicin—bone cancer	0.0028	0.00383	CcSEcCtD
Abacavir—Lethargy—Epirubicin—bone cancer	0.00277	0.0038	CcSEcCtD
Abacavir—Convulsion—Cisplatin—bone cancer	0.00276	0.00378	CcSEcCtD
Abacavir—Myalgia—Cisplatin—bone cancer	0.00271	0.00371	CcSEcCtD
Abacavir—Anxiety—Cisplatin—bone cancer	0.0027	0.0037	CcSEcCtD
Abacavir—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—bone cancer	0.00269	0.00369	CcSEcCtD
Abacavir—Liver function test abnormal—Methotrexate—bone cancer	0.00268	0.00367	CcSEcCtD
Abacavir—Discomfort—Cisplatin—bone cancer	0.00268	0.00367	CcSEcCtD
Abacavir—Migraine—Epirubicin—bone cancer	0.00267	0.00366	CcSEcCtD
Abacavir—UGT1A1—Phase II conjugation—GSTP1—bone cancer	0.00263	0.00974	CbGpPWpGaD
Abacavir—Toxic epidermal necrolysis—Methotrexate—bone cancer	0.00261	0.00358	CcSEcCtD
Abacavir—Oedema—Cisplatin—bone cancer	0.0026	0.00356	CcSEcCtD
Abacavir—Anaphylactic shock—Cisplatin—bone cancer	0.0026	0.00356	CcSEcCtD
Abacavir—Infection—Cisplatin—bone cancer	0.00258	0.00354	CcSEcCtD
Abacavir—Lethargy—Doxorubicin—bone cancer	0.00256	0.00351	CcSEcCtD
Abacavir—Nervous system disorder—Cisplatin—bone cancer	0.00255	0.00349	CcSEcCtD
Abacavir—Thrombocytopenia—Cisplatin—bone cancer	0.00254	0.00349	CcSEcCtD
Abacavir—Blood creatinine increased—Epirubicin—bone cancer	0.00254	0.00349	CcSEcCtD
Abacavir—Skin disorder—Cisplatin—bone cancer	0.00252	0.00346	CcSEcCtD
Abacavir—Liver function test abnormal—Epirubicin—bone cancer	0.00251	0.00343	CcSEcCtD
Abacavir—Abdominal pain upper—Epirubicin—bone cancer	0.00248	0.0034	CcSEcCtD
Abacavir—Anorexia—Cisplatin—bone cancer	0.00248	0.00339	CcSEcCtD
Abacavir—ADH6—Metabolism—ENO2—bone cancer	0.00248	0.00918	CbGpPWpGaD
Abacavir—Migraine—Doxorubicin—bone cancer	0.00247	0.00339	CcSEcCtD
Abacavir—Pancreatitis—Methotrexate—bone cancer	0.00246	0.00337	CcSEcCtD
Abacavir—Toxic epidermal necrolysis—Epirubicin—bone cancer	0.00245	0.00335	CcSEcCtD
Abacavir—Aspartate aminotransferase increased—Epirubicin—bone cancer	0.00245	0.00335	CcSEcCtD
Abacavir—Hypotension—Cisplatin—bone cancer	0.00243	0.00333	CcSEcCtD
Abacavir—Abdominal discomfort—Methotrexate—bone cancer	0.0024	0.00329	CcSEcCtD
Abacavir—Gastritis—Epirubicin—bone cancer	0.0024	0.00329	CcSEcCtD
Abacavir—Muscular weakness—Epirubicin—bone cancer	0.0024	0.00328	CcSEcCtD
Abacavir—Alanine aminotransferase increased—Epirubicin—bone cancer	0.0024	0.00328	CcSEcCtD
Abacavir—Musculoskeletal discomfort—Cisplatin—bone cancer	0.00237	0.00324	CcSEcCtD
Abacavir—Blood creatinine increased—Doxorubicin—bone cancer	0.00235	0.00322	CcSEcCtD
Abacavir—Neutropenia—Methotrexate—bone cancer	0.00235	0.00321	CcSEcCtD
Abacavir—Paraesthesia—Cisplatin—bone cancer	0.00233	0.0032	CcSEcCtD
Abacavir—Liver function test abnormal—Doxorubicin—bone cancer	0.00232	0.00318	CcSEcCtD
Abacavir—Dyspnoea—Cisplatin—bone cancer	0.00232	0.00317	CcSEcCtD
Abacavir—Pancreatitis—Epirubicin—bone cancer	0.0023	0.00315	CcSEcCtD
Abacavir—ADH6—Metabolism—DHFR—bone cancer	0.0023	0.00851	CbGpPWpGaD
Abacavir—Abdominal pain upper—Doxorubicin—bone cancer	0.0023	0.00314	CcSEcCtD
Abacavir—Toxic epidermal necrolysis—Doxorubicin—bone cancer	0.00226	0.0031	CcSEcCtD
Abacavir—Aspartate aminotransferase increased—Doxorubicin—bone cancer	0.00226	0.0031	CcSEcCtD
Abacavir—Decreased appetite—Cisplatin—bone cancer	0.00226	0.0031	CcSEcCtD
Abacavir—Bronchitis—Epirubicin—bone cancer	0.00226	0.00309	CcSEcCtD
Abacavir—Pneumonia—Methotrexate—bone cancer	0.00225	0.00308	CcSEcCtD
Abacavir—Gastrointestinal disorder—Cisplatin—bone cancer	0.00224	0.00307	CcSEcCtD
Abacavir—Depression—Methotrexate—bone cancer	0.00223	0.00305	CcSEcCtD
Abacavir—Gastritis—Doxorubicin—bone cancer	0.00222	0.00305	CcSEcCtD
Abacavir—Pain—Cisplatin—bone cancer	0.00222	0.00304	CcSEcCtD
Abacavir—Stevens-Johnson syndrome—Methotrexate—bone cancer	0.00222	0.00304	CcSEcCtD
Abacavir—Muscular weakness—Doxorubicin—bone cancer	0.00222	0.00304	CcSEcCtD
Abacavir—Alanine aminotransferase increased—Doxorubicin—bone cancer	0.00222	0.00304	CcSEcCtD
Abacavir—Renal failure—Methotrexate—bone cancer	0.0022	0.00301	CcSEcCtD
Abacavir—Neutropenia—Epirubicin—bone cancer	0.00219	0.00301	CcSEcCtD
Abacavir—Stomatitis—Methotrexate—bone cancer	0.00218	0.00299	CcSEcCtD
Abacavir—Conjunctivitis—Methotrexate—bone cancer	0.00217	0.00298	CcSEcCtD
Abacavir—ADH6—Metabolism—GNA11—bone cancer	0.00215	0.00796	CbGpPWpGaD
Abacavir—Feeling abnormal—Cisplatin—bone cancer	0.00214	0.00293	CcSEcCtD
Abacavir—Pancreatitis—Doxorubicin—bone cancer	0.00213	0.00292	CcSEcCtD
Abacavir—Hyperglycaemia—Epirubicin—bone cancer	0.00212	0.0029	CcSEcCtD
Abacavir—Hepatobiliary disease—Methotrexate—bone cancer	0.00212	0.0029	CcSEcCtD
Abacavir—Pneumonia—Epirubicin—bone cancer	0.00211	0.00288	CcSEcCtD
Abacavir—Bronchitis—Doxorubicin—bone cancer	0.00209	0.00286	CcSEcCtD
Abacavir—Stevens-Johnson syndrome—Epirubicin—bone cancer	0.00207	0.00284	CcSEcCtD
Abacavir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—JUN—bone cancer	0.00206	0.00765	CbGpPWpGaD
Abacavir—Renal failure—Epirubicin—bone cancer	0.00206	0.00282	CcSEcCtD
Abacavir—Body temperature increased—Cisplatin—bone cancer	0.00205	0.00281	CcSEcCtD
Abacavir—Neuropathy peripheral—Epirubicin—bone cancer	0.00205	0.00281	CcSEcCtD
Abacavir—Stomatitis—Epirubicin—bone cancer	0.00204	0.00279	CcSEcCtD
Abacavir—Conjunctivitis—Epirubicin—bone cancer	0.00203	0.00279	CcSEcCtD
Abacavir—Neutropenia—Doxorubicin—bone cancer	0.00203	0.00278	CcSEcCtD
Abacavir—Hepatitis—Methotrexate—bone cancer	0.00201	0.00275	CcSEcCtD
Abacavir—Pharyngitis—Methotrexate—bone cancer	0.00199	0.00273	CcSEcCtD
Abacavir—Hepatobiliary disease—Epirubicin—bone cancer	0.00198	0.00271	CcSEcCtD
Abacavir—Hyperglycaemia—Doxorubicin—bone cancer	0.00196	0.00268	CcSEcCtD
Abacavir—Pneumonia—Doxorubicin—bone cancer	0.00195	0.00267	CcSEcCtD
Abacavir—ADH6—Metabolism—CYP3A4—bone cancer	0.00195	0.00721	CbGpPWpGaD
Abacavir—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.00192	0.00263	CcSEcCtD
Abacavir—Hypersensitivity—Cisplatin—bone cancer	0.00192	0.00262	CcSEcCtD
Abacavir—Renal failure—Doxorubicin—bone cancer	0.0019	0.00261	CcSEcCtD
Abacavir—Erythema multiforme—Methotrexate—bone cancer	0.0019	0.0026	CcSEcCtD
Abacavir—Neuropathy peripheral—Doxorubicin—bone cancer	0.0019	0.0026	CcSEcCtD
Abacavir—Stomatitis—Doxorubicin—bone cancer	0.00189	0.00259	CcSEcCtD
Abacavir—Conjunctivitis—Doxorubicin—bone cancer	0.00188	0.00258	CcSEcCtD
Abacavir—Hepatitis—Epirubicin—bone cancer	0.00188	0.00257	CcSEcCtD
Abacavir—Asthenia—Cisplatin—bone cancer	0.00186	0.00255	CcSEcCtD
Abacavir—Pharyngitis—Epirubicin—bone cancer	0.00186	0.00255	CcSEcCtD
Abacavir—Connective tissue disorder—Epirubicin—bone cancer	0.00185	0.00253	CcSEcCtD
Abacavir—Hepatobiliary disease—Doxorubicin—bone cancer	0.00183	0.00251	CcSEcCtD
Abacavir—Immune system disorder—Methotrexate—bone cancer	0.00181	0.00248	CcSEcCtD
Abacavir—Chills—Methotrexate—bone cancer	0.0018	0.00247	CcSEcCtD
Abacavir—UGT1A1—Biological oxidations—CYP3A4—bone cancer	0.0018	0.00666	CbGpPWpGaD
Abacavir—Diarrhoea—Cisplatin—bone cancer	0.00178	0.00244	CcSEcCtD
Abacavir—Erythema multiforme—Epirubicin—bone cancer	0.00178	0.00243	CcSEcCtD
Abacavir—UGT1A1—Metapathway biotransformation—CYP3A4—bone cancer	0.00177	0.00657	CbGpPWpGaD
Abacavir—Alopecia—Methotrexate—bone cancer	0.00177	0.00243	CcSEcCtD
Abacavir—UGT1A1—NRF2 pathway—TGFBR2—bone cancer	0.00175	0.0065	CbGpPWpGaD
Abacavir—UGT1A1—NRF2 pathway—GSTP1—bone cancer	0.00175	0.0065	CbGpPWpGaD
Abacavir—Malnutrition—Methotrexate—bone cancer	0.00175	0.00239	CcSEcCtD
Abacavir—Hepatitis—Doxorubicin—bone cancer	0.00174	0.00238	CcSEcCtD
Abacavir—Pharyngitis—Doxorubicin—bone cancer	0.00173	0.00236	CcSEcCtD
Abacavir—Connective tissue disorder—Doxorubicin—bone cancer	0.00171	0.00234	CcSEcCtD
Abacavir—Immune system disorder—Epirubicin—bone cancer	0.0017	0.00232	CcSEcCtD
Abacavir—Chills—Epirubicin—bone cancer	0.00169	0.00231	CcSEcCtD
Abacavir—ADH6—Metabolism—GSTP1—bone cancer	0.00167	0.00617	CbGpPWpGaD
Abacavir—Alopecia—Epirubicin—bone cancer	0.00166	0.00227	CcSEcCtD
Abacavir—Vomiting—Cisplatin—bone cancer	0.00165	0.00226	CcSEcCtD
Abacavir—Erythema multiforme—Doxorubicin—bone cancer	0.00164	0.00225	CcSEcCtD
Abacavir—Rash—Cisplatin—bone cancer	0.00164	0.00225	CcSEcCtD
Abacavir—Dermatitis—Cisplatin—bone cancer	0.00164	0.00224	CcSEcCtD
Abacavir—Malnutrition—Epirubicin—bone cancer	0.00164	0.00224	CcSEcCtD
Abacavir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	0.00162	0.00601	CbGpPWpGaD
Abacavir—Ill-defined disorder—Methotrexate—bone cancer	0.00162	0.00222	CcSEcCtD
Abacavir—Anaemia—Methotrexate—bone cancer	0.00162	0.00221	CcSEcCtD
Abacavir—Malaise—Methotrexate—bone cancer	0.00158	0.00216	CcSEcCtD
Abacavir—Immune system disorder—Doxorubicin—bone cancer	0.00157	0.00215	CcSEcCtD
Abacavir—Vertigo—Methotrexate—bone cancer	0.00157	0.00215	CcSEcCtD
Abacavir—Leukopenia—Methotrexate—bone cancer	0.00156	0.00214	CcSEcCtD
Abacavir—Chills—Doxorubicin—bone cancer	0.00156	0.00214	CcSEcCtD
Abacavir—Nausea—Cisplatin—bone cancer	0.00154	0.00212	CcSEcCtD
Abacavir—UGT1A1—Biological oxidations—GSTP1—bone cancer	0.00154	0.0057	CbGpPWpGaD
Abacavir—Alopecia—Doxorubicin—bone cancer	0.00154	0.0021	CcSEcCtD
Abacavir—Cough—Methotrexate—bone cancer	0.00153	0.00209	CcSEcCtD
Abacavir—UGT1A1—Metapathway biotransformation—GSTP1—bone cancer	0.00152	0.00562	CbGpPWpGaD
Abacavir—Ill-defined disorder—Epirubicin—bone cancer	0.00152	0.00208	CcSEcCtD
Abacavir—Convulsion—Methotrexate—bone cancer	0.00151	0.00207	CcSEcCtD
Abacavir—Malnutrition—Doxorubicin—bone cancer	0.00151	0.00207	CcSEcCtD
Abacavir—Anaemia—Epirubicin—bone cancer	0.00151	0.00207	CcSEcCtD
Abacavir—Arthralgia—Methotrexate—bone cancer	0.00149	0.00204	CcSEcCtD
Abacavir—Myalgia—Methotrexate—bone cancer	0.00149	0.00204	CcSEcCtD
Abacavir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.00148	0.00202	CcSEcCtD
Abacavir—Malaise—Epirubicin—bone cancer	0.00147	0.00202	CcSEcCtD
Abacavir—Discomfort—Methotrexate—bone cancer	0.00147	0.00201	CcSEcCtD
Abacavir—Vertigo—Epirubicin—bone cancer	0.00147	0.00201	CcSEcCtD
Abacavir—Leukopenia—Epirubicin—bone cancer	0.00146	0.00201	CcSEcCtD
Abacavir—Cough—Epirubicin—bone cancer	0.00143	0.00196	CcSEcCtD
Abacavir—Anaphylactic shock—Methotrexate—bone cancer	0.00143	0.00195	CcSEcCtD
Abacavir—Convulsion—Epirubicin—bone cancer	0.00142	0.00194	CcSEcCtD
Abacavir—Infection—Methotrexate—bone cancer	0.00142	0.00194	CcSEcCtD
Abacavir—Ill-defined disorder—Doxorubicin—bone cancer	0.0014	0.00192	CcSEcCtD
Abacavir—Nervous system disorder—Methotrexate—bone cancer	0.0014	0.00192	CcSEcCtD
Abacavir—Anaemia—Doxorubicin—bone cancer	0.0014	0.00192	CcSEcCtD
Abacavir—Thrombocytopenia—Methotrexate—bone cancer	0.0014	0.00191	CcSEcCtD
Abacavir—Arthralgia—Epirubicin—bone cancer	0.00139	0.00191	CcSEcCtD
Abacavir—Myalgia—Epirubicin—bone cancer	0.00139	0.00191	CcSEcCtD
Abacavir—Anxiety—Epirubicin—bone cancer	0.00139	0.0019	CcSEcCtD
Abacavir—Skin disorder—Methotrexate—bone cancer	0.00139	0.0019	CcSEcCtD
Abacavir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.00138	0.00189	CcSEcCtD
Abacavir—Discomfort—Epirubicin—bone cancer	0.00138	0.00188	CcSEcCtD
Abacavir—Malaise—Doxorubicin—bone cancer	0.00136	0.00187	CcSEcCtD
Abacavir—Vertigo—Doxorubicin—bone cancer	0.00136	0.00186	CcSEcCtD
Abacavir—Anorexia—Methotrexate—bone cancer	0.00136	0.00186	CcSEcCtD
Abacavir—Leukopenia—Doxorubicin—bone cancer	0.00135	0.00186	CcSEcCtD
Abacavir—Anaphylactic shock—Epirubicin—bone cancer	0.00133	0.00183	CcSEcCtD
Abacavir—Oedema—Epirubicin—bone cancer	0.00133	0.00183	CcSEcCtD
Abacavir—Hypotension—Methotrexate—bone cancer	0.00133	0.00183	CcSEcCtD
Abacavir—Infection—Epirubicin—bone cancer	0.00133	0.00182	CcSEcCtD
Abacavir—ADK—Metabolism—ENO2—bone cancer	0.00132	0.0049	CbGpPWpGaD
Abacavir—Cough—Doxorubicin—bone cancer	0.00132	0.00181	CcSEcCtD
Abacavir—Convulsion—Doxorubicin—bone cancer	0.00131	0.0018	CcSEcCtD
Abacavir—Nervous system disorder—Epirubicin—bone cancer	0.00131	0.00179	CcSEcCtD
Abacavir—Thrombocytopenia—Epirubicin—bone cancer	0.00131	0.00179	CcSEcCtD
Abacavir—Musculoskeletal discomfort—Methotrexate—bone cancer	0.0013	0.00178	CcSEcCtD
Abacavir—Skin disorder—Epirubicin—bone cancer	0.0013	0.00178	CcSEcCtD
Abacavir—Insomnia—Methotrexate—bone cancer	0.00129	0.00177	CcSEcCtD
Abacavir—Myalgia—Doxorubicin—bone cancer	0.00129	0.00176	CcSEcCtD
Abacavir—Arthralgia—Doxorubicin—bone cancer	0.00129	0.00176	CcSEcCtD
Abacavir—Anxiety—Doxorubicin—bone cancer	0.00128	0.00176	CcSEcCtD
Abacavir—Paraesthesia—Methotrexate—bone cancer	0.00128	0.00175	CcSEcCtD
Abacavir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.00128	0.00175	CcSEcCtD
Abacavir—Discomfort—Doxorubicin—bone cancer	0.00127	0.00174	CcSEcCtD
Abacavir—Anorexia—Epirubicin—bone cancer	0.00127	0.00174	CcSEcCtD
Abacavir—Dyspnoea—Methotrexate—bone cancer	0.00127	0.00174	CcSEcCtD
Abacavir—Hypotension—Epirubicin—bone cancer	0.00125	0.00171	CcSEcCtD
Abacavir—Decreased appetite—Methotrexate—bone cancer	0.00124	0.0017	CcSEcCtD
Abacavir—Oedema—Doxorubicin—bone cancer	0.00124	0.00169	CcSEcCtD
Abacavir—Anaphylactic shock—Doxorubicin—bone cancer	0.00124	0.00169	CcSEcCtD
Abacavir—Gastrointestinal disorder—Methotrexate—bone cancer	0.00123	0.00169	CcSEcCtD
Abacavir—Fatigue—Methotrexate—bone cancer	0.00123	0.00168	CcSEcCtD
Abacavir—ADK—Metabolism—DHFR—bone cancer	0.00123	0.00455	CbGpPWpGaD
Abacavir—Infection—Doxorubicin—bone cancer	0.00123	0.00168	CcSEcCtD
Abacavir—Pain—Methotrexate—bone cancer	0.00122	0.00167	CcSEcCtD
Abacavir—Musculoskeletal discomfort—Epirubicin—bone cancer	0.00122	0.00167	CcSEcCtD
Abacavir—Nervous system disorder—Doxorubicin—bone cancer	0.00121	0.00166	CcSEcCtD
Abacavir—Thrombocytopenia—Doxorubicin—bone cancer	0.00121	0.00166	CcSEcCtD
Abacavir—Insomnia—Epirubicin—bone cancer	0.00121	0.00165	CcSEcCtD
Abacavir—Skin disorder—Doxorubicin—bone cancer	0.0012	0.00164	CcSEcCtD
Abacavir—Paraesthesia—Epirubicin—bone cancer	0.0012	0.00164	CcSEcCtD
Abacavir—Dyspnoea—Epirubicin—bone cancer	0.00119	0.00163	CcSEcCtD
Abacavir—Anorexia—Doxorubicin—bone cancer	0.00118	0.00161	CcSEcCtD
Abacavir—Feeling abnormal—Methotrexate—bone cancer	0.00118	0.00161	CcSEcCtD
Abacavir—Gastrointestinal pain—Methotrexate—bone cancer	0.00117	0.0016	CcSEcCtD
Abacavir—Decreased appetite—Epirubicin—bone cancer	0.00116	0.00159	CcSEcCtD
Abacavir—Hypotension—Doxorubicin—bone cancer	0.00115	0.00158	CcSEcCtD
Abacavir—Gastrointestinal disorder—Epirubicin—bone cancer	0.00115	0.00158	CcSEcCtD
Abacavir—Fatigue—Epirubicin—bone cancer	0.00115	0.00158	CcSEcCtD
Abacavir—ADK—Metabolism—GNA11—bone cancer	0.00115	0.00425	CbGpPWpGaD
Abacavir—Pain—Epirubicin—bone cancer	0.00114	0.00156	CcSEcCtD
Abacavir—Urticaria—Methotrexate—bone cancer	0.00113	0.00155	CcSEcCtD
Abacavir—Abdominal pain—Methotrexate—bone cancer	0.00113	0.00154	CcSEcCtD
Abacavir—Body temperature increased—Methotrexate—bone cancer	0.00113	0.00154	CcSEcCtD
Abacavir—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.00113	0.00154	CcSEcCtD
Abacavir—Insomnia—Doxorubicin—bone cancer	0.00112	0.00153	CcSEcCtD
Abacavir—Paraesthesia—Doxorubicin—bone cancer	0.00111	0.00152	CcSEcCtD
Abacavir—Dyspnoea—Doxorubicin—bone cancer	0.0011	0.00151	CcSEcCtD
Abacavir—Feeling abnormal—Epirubicin—bone cancer	0.0011	0.00151	CcSEcCtD
Abacavir—Gastrointestinal pain—Epirubicin—bone cancer	0.00109	0.0015	CcSEcCtD
Abacavir—UGT1A1—Metabolism—NDUFA12—bone cancer	0.00108	0.00399	CbGpPWpGaD
Abacavir—Decreased appetite—Doxorubicin—bone cancer	0.00107	0.00147	CcSEcCtD
Abacavir—Gastrointestinal disorder—Doxorubicin—bone cancer	0.00107	0.00146	CcSEcCtD
Abacavir—Fatigue—Doxorubicin—bone cancer	0.00106	0.00146	CcSEcCtD
Abacavir—Urticaria—Epirubicin—bone cancer	0.00106	0.00145	CcSEcCtD
Abacavir—Pain—Doxorubicin—bone cancer	0.00106	0.00145	CcSEcCtD
Abacavir—Body temperature increased—Epirubicin—bone cancer	0.00106	0.00145	CcSEcCtD
Abacavir—Abdominal pain—Epirubicin—bone cancer	0.00106	0.00145	CcSEcCtD
Abacavir—Hypersensitivity—Methotrexate—bone cancer	0.00105	0.00144	CcSEcCtD
Abacavir—ADK—Metabolism—CYP3A4—bone cancer	0.00104	0.00385	CbGpPWpGaD
Abacavir—Asthenia—Methotrexate—bone cancer	0.00102	0.0014	CcSEcCtD
Abacavir—Feeling abnormal—Doxorubicin—bone cancer	0.00102	0.00139	CcSEcCtD
Abacavir—Gastrointestinal pain—Doxorubicin—bone cancer	0.00101	0.00138	CcSEcCtD
Abacavir—Pruritus—Methotrexate—bone cancer	0.00101	0.00138	CcSEcCtD
Abacavir—Hypersensitivity—Epirubicin—bone cancer	0.000983	0.00135	CcSEcCtD
Abacavir—Urticaria—Doxorubicin—bone cancer	0.000981	0.00134	CcSEcCtD
Abacavir—Abdominal pain—Doxorubicin—bone cancer	0.000976	0.00134	CcSEcCtD
Abacavir—Body temperature increased—Doxorubicin—bone cancer	0.000976	0.00134	CcSEcCtD
Abacavir—Diarrhoea—Methotrexate—bone cancer	0.000976	0.00134	CcSEcCtD
Abacavir—Asthenia—Epirubicin—bone cancer	0.000958	0.00131	CcSEcCtD
Abacavir—Pruritus—Epirubicin—bone cancer	0.000944	0.00129	CcSEcCtD
Abacavir—Dizziness—Methotrexate—bone cancer	0.000943	0.00129	CcSEcCtD
Abacavir—Diarrhoea—Epirubicin—bone cancer	0.000913	0.00125	CcSEcCtD
Abacavir—Hypersensitivity—Doxorubicin—bone cancer	0.00091	0.00125	CcSEcCtD
Abacavir—Vomiting—Methotrexate—bone cancer	0.000907	0.00124	CcSEcCtD
Abacavir—Rash—Methotrexate—bone cancer	0.000899	0.00123	CcSEcCtD
Abacavir—Dermatitis—Methotrexate—bone cancer	0.000899	0.00123	CcSEcCtD
Abacavir—UGT1A1—Metabolism—NT5C3A—bone cancer	0.000894	0.00331	CbGpPWpGaD
Abacavir—Headache—Methotrexate—bone cancer	0.000894	0.00122	CcSEcCtD
Abacavir—ADK—Metabolism—GSTP1—bone cancer	0.000889	0.00329	CbGpPWpGaD
Abacavir—Asthenia—Doxorubicin—bone cancer	0.000886	0.00121	CcSEcCtD
Abacavir—Dizziness—Epirubicin—bone cancer	0.000883	0.00121	CcSEcCtD
Abacavir—Pruritus—Doxorubicin—bone cancer	0.000874	0.0012	CcSEcCtD
Abacavir—ADH6—Metabolism—PTGS2—bone cancer	0.000863	0.0032	CbGpPWpGaD
Abacavir—Vomiting—Epirubicin—bone cancer	0.000849	0.00116	CcSEcCtD
Abacavir—Nausea—Methotrexate—bone cancer	0.000847	0.00116	CcSEcCtD
Abacavir—Diarrhoea—Doxorubicin—bone cancer	0.000845	0.00116	CcSEcCtD
Abacavir—Rash—Epirubicin—bone cancer	0.000842	0.00115	CcSEcCtD
Abacavir—Dermatitis—Epirubicin—bone cancer	0.000841	0.00115	CcSEcCtD
Abacavir—Headache—Epirubicin—bone cancer	0.000836	0.00115	CcSEcCtD
Abacavir—Dizziness—Doxorubicin—bone cancer	0.000817	0.00112	CcSEcCtD
Abacavir—Nausea—Epirubicin—bone cancer	0.000793	0.00109	CcSEcCtD
Abacavir—Vomiting—Doxorubicin—bone cancer	0.000785	0.00108	CcSEcCtD
Abacavir—Rash—Doxorubicin—bone cancer	0.000779	0.00107	CcSEcCtD
Abacavir—Dermatitis—Doxorubicin—bone cancer	0.000778	0.00107	CcSEcCtD
Abacavir—Headache—Doxorubicin—bone cancer	0.000774	0.00106	CcSEcCtD
Abacavir—Nausea—Doxorubicin—bone cancer	0.000734	0.001	CcSEcCtD
Abacavir—ADK—Metabolism—PTGS2—bone cancer	0.000461	0.00171	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—ENO2—bone cancer	0.000391	0.00145	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—DHFR—bone cancer	0.000363	0.00134	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—GNA11—bone cancer	0.000339	0.00126	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—CYP3A4—bone cancer	0.000308	0.00114	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—GSTP1—bone cancer	0.000263	0.000975	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—PTGS2—bone cancer	0.000136	0.000505	CbGpPWpGaD
